Inventor · disambiguated record
David Peritt
Also filed as: PERITT DAVID · PERITT DAVID L
33 granted patents·23 pending applications·705 citations·filing 2001–2024
98Inventor score
Files withJANSSEN BIOTECH INC12GILES-KOMAR JILL8SIGILON THERAPEUTICS INC8CENTOCOR INC7MALLINCKRODT HOSPITAL PRODUCTS IP LTD4
Top patents by PatentIndex Score
56 records- 0199US6902734B2Anti-IL-12 antibodies and compositions thereofCENTOCOR INC·Filed 2001·Granted Jun 7, 2005·147 cites·4 claims
- 0298US7955597B2Anti-IL-6 antibodies, compositions, methods and usesCENTOCOR INC·Filed 2009·Granted Jun 7, 2011·61 cites·5 claims
- 0398US7612182B2Anti-IL-6 antibodies, compositions, methods and usesCENTOCOR INC·Filed 2007·Granted Nov 3, 2009·76 cites·15 claims
- 0498US7291721B2Anti-IL-6 antibodies, compositions, methods and usesCENTOCOR INC·Filed 2002·Granted Nov 6, 2007·162 cites·9 claims
- 0597US7833786B2Anti-IL-6 antibodies, compositions, methods and usesCENTOCOR INC·Filed 2007·Granted Nov 16, 2010·44 cites·4 claims
- 0697US7560247B2Nucleic acids encoding anti-IL-12 antibodies, and methods of productionCENTOCOR ORTHO BIOTECH INC·Filed 2007·Granted Jul 14, 2009·29 cites·10 claims
- 0795US7279157B2Method for treating psoriasis by administering an anti-il-12 antibodyCENTOCOR INC·Filed 2004·Granted Oct 9, 2007·35 cites·4 claims
- 0895US7166285B2Anti-IL-12 antibodies and compositionsCENTOCOR INC·Filed 2004·Granted Jan 23, 2007·38 cites·4 claims
- 0994US10259867B2Method for treating lupus by administering an anti-IL-12 antibodyJANSSEN BIOTECH INC·Filed 2017·Granted Apr 16, 2019·7 cites·16 claims
- 1094US7063964B2Nucleic acids encoding IL-12 antibodyGILES-KOMAR JILL·Filed 2004·Granted Jun 20, 2006·32 cites·5 claims
- 1192US10926020B2Processing bloodMALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2018·Granted Feb 23, 2021·3 cites·20 claims
- 1292US9676848B2Anti-IL-12 antibodies and compositionsGILES-KOMAR JILL·Filed 2016·Granted Jun 13, 2017·6 cites·10 claims
- 1391US10519231B2Method for treating lupus by administering an anti-IL-12 antibodyJANSSEN BIOTECH INC·Filed 2019·Granted Dec 31, 2019·4 cites·12 claims
- 1491US9428579B2Method of treating Crohn's disease by administering an anti-IL-12 antibodyJANSSEN BIOTECH INC·Filed 2014·Granted Aug 30, 2016·8 cites·8 claims
- 1591US8080247B2Anti-IL-12 antibodiesGILES-KOMAR JILL·Filed 2005·Granted Dec 20, 2011·10 cites·10 claims
- 1690US7887807B2Anti-IL-12 antibodies and compositionsCENTOCOR ORTHO BIOTECH INC·Filed 2009·Granted Feb 15, 2011·7 cites·6 claims
- 1789US8703141B2Method for treating Crohn's disease by administering an anti-IL-12 antibodyJANSSEN BIOTECH INC·Filed 2012·Granted Apr 22, 2014·5 cites·12 claims
- 1889US8329171B2Method for treating psoriatic arthritis by administering an anti-IL-12 antibodyGILES-KOMAR JILL·Filed 2011·Granted Dec 11, 2012·6 cites·12 claims
- 1988US9409984B2Method for treating psoriasis by administering an anti-IL-12 antibodyJANSSEN BIOTECH INC·Filed 2014·Granted Aug 9, 2016·5 cites·4 claims
- 2088US8084233B2Nucleic acids encoding anti-IL-12 antibodyGILES-KOMAR JILL·Filed 2010·Granted Dec 27, 2011·6 cites·14 claims
- 2187US9862766B2Method of treating lupus by administering an anti-IL-12 antibodyJANSSEN BIOTECH INC·Filed 2017·Granted Jan 9, 2018·3 cites·10 claims
- 2284US8329170B2Method for treating psoriasis by administering an anti-IL-12 antibodyGILES-KOMAR JILL·Filed 2011·Granted Dec 11, 2012·4 cites·8 claims
- 2382US10953149B2Processing bloodMALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2018·Granted Mar 23, 2021·2 cites·24 claims
- 2482US10940259B2Processing bloodMALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2018·Granted Mar 9, 2021·2 cites·24 claims
- 2578US12161760B2Implantable particles and related methodsSIGILON THERAPEUTICS INC·Filed 2019·Granted Dec 10, 2024·2 cites·27 claims
- 2677US11078267B2Method for treating lupus by administering an anti-IL-12 antibodyJANSSEN BIOTECH INC·Filed 2019·Granted Aug 3, 2021·0 cites·4 claims
- 2772US2025235409A1Implantable particles and related methodsSIGILON THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2871US12447253B2Processing bloodTHERAKOS DEVELOPMENT LTD·Filed 2021·Granted Oct 21, 2025·0 cites·20 claims
- 2969US2019085069A1Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and UsesJANSSEN BIOTECH INC·Filed 2018·Application pending·0 cites
- 3067US11124767B2Use of apoptotic cells ex vivo to generate regulatory T cellsMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2018·Granted Sep 21, 2021·0 cites·8 claims
- 3167US2021388318A1Use of apoptotic cells ex vivo to generate regulatory t cellsMALLINCKRODT PHARMACEUTICALS IRELAND LTD·Filed 2021·Application pending·0 cites
- 3267US2024139393A1Systems and methods for closed loop, real-time modifications of patient cellsLUPAGEN INC·Filed 2024·Application pending·0 cites
- 3366US9605067B2Nucleic acids encoding anti-IL-12 antibodyJANSSEN BIOTECH INC·Filed 2016·Granted Mar 28, 2017·0 cites·10 claims
- 3466US2018079809A1Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and UsesJANSSEN BIOTECH INC·Filed 2017·Application pending·0 cites
- 3565US8894990B2Method for treating psoriatic arthritis by administering an anti-IL-12 antibodyJANSSEN BIOTECH INC·Filed 2012·Granted Nov 25, 2014·0 cites·8 claims
- 3665US2014141013A1Anti-il-6 antibodies, compositions, methods and usesJANSSEN BIOTECH INC·Filed 2014·Application pending·0 cites
- 3763US9169461B2Use of apoptotic cells ex vivo to generate regulatory T cellsPERITT DAVID·Filed 2006·Granted Oct 27, 2015·1 cites·4 claims
- 3862US2005002937A1Anti-IL-12 antibodies, compositions, methods and usesFiled 2004·Application pending·0 cites
- 3960US2012096569A1Anti-il-6 antibodies,compositions, methods and usesGILES-KOMAR JILL·Filed 2011·Application pending·0 cites
- 4058US2011218329A1Anti-il-6 antibodies, compositions, methods and usesGILES-KOMAR JILL·Filed 2011·Application pending·0 cites
- 4157US11904081B2Systems and methods for closed loop, real-time modifications of patient cellsLUPAGEN INC·Filed 2019·Granted Feb 20, 2024·0 cites·19 claims
- 4254US2023233679A1Compositions, devices and methods for inducing immune responses to infectious agentsSIGILON THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4352US10138464B2Use of apoptotic cells ex vivo to generate regulatory T cellsMALLINCKRODT HOSPITAL PRODUCTS IP LTD·Filed 2015·Granted Nov 27, 2018·0 cites·11 claims
- 4452US2003157073A1Methods for pretreating a subject with apoptotic cellsFiled 2002·Application pending·0 cites
- 4552US2003139466A1Methods for pretreating a subject with extracorporeal photopheresisFiled 2002·Application pending·0 cites
- 4649US2005063944A1Method of inducing maturation of dendritic cells and uses thereforFiled 2003·Application pending·0 cites
- 4749US2003157105A1Anti-p40 immunglobulin derived proteins, compositions, methods and usesFiled 2002·Application pending·0 cites
- 4847US2023123802A1Compositions, devices, and methods for factor vii therapySIGILON THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4946US2021145889A1Methods, compositions, and implantable elements comprising stem cellsSIGILON THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 5044US2003166303A1Novel screening method for molecular antagonist using flow-cytometryFiled 2002·Application pending·0 cites
Showing the top 50 of 56 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David Peritt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →